New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesGiovanni Palladini, Giampaolo Merlini, Stefan Schönland et al.|Journal of Clinical Oncology|2012Cited by 965
Systemic immunoglobulin light chain amyloidosisGiampaolo Merlini, Morie A. Gertz, Angela Dispenzieri et al.|Nature Reviews Disease Primers|2018Cited by 550
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ DysfunctionMorie A. Gertz, Michaela Liedtke, Spencer Guthrie et al.|Journal of Clinical Oncology|2016Cited by 206